Sphere Fluidics' Blog

Insights from Matthew Dalby, Professor of Cell Engineering, University of Glasgow

Insights from Professor Wilhelm Huck

Cyto-Mine® reduces the cell line development process by 3 months, enabling researchers to make a new vaccine much faster

We are trying, like all of...

Cell line development (CLD) follows a little changed process from that used in the early days of biopharmaceutical development. The steps to create...

Dr Fay Saunders, UK Head of Upstream Mammalian Cell Culture, Process Development at FUJIFILM Diosynth Biotechnologies, shares her experience of...

In the 1960s, the discovery that human cancer cells expressed cell-surface antigens was revolutionary in the development of antibody-based treatments...

Dr Tristan Vaughan is Vice President of Research and Development, Antibody Discovery and Protein Engineering (ADPE) at AstraZeneca, Cambridge, UK....

Since launch of the first therapeutic monoclonal antibody in 1986, antibody-based biologics have become a major class of modern medicine. With the...